Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

In vivo reversal of depolarizing neuromuscular blockade.

Riker WF Jr, Okamoto M, Artusio JF Jr.

Arch Int Pharmacodyn Ther. 1995 Jul-Aug;330(1):90-101.

PMID:
8849313
2.

Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.

Okamoto M, Walewski JL, Artusio JF Jr, Riker WF Jr.

Anesth Analg. 1992 Sep;75(3):361-71.

PMID:
1324625
3.
4.

Memory impairment in myasthenia gravis.

Riker WF.

Neurology. 1989 Apr;39(4):611-2. No abstract available.

PMID:
2927695
5.

Motor nerve ending disorder in myasthenia gravis.

Roe RD, Riker WF, Standaert FG.

Neurology. 1988 Feb;38(2):293-7.

PMID:
2829056
6.

Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin.

Hartman GS, Fiamengo SA, Riker WF Jr.

Anesthesiology. 1986 Oct;65(4):405-13.

PMID:
3767039
7.

Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.

Sprouse JS, Baker T, Riker WF Jr.

J Pharmacol Exp Ther. 1985 Dec;235(3):864-72.

PMID:
4078737
8.

d-Tubocurarine sensitivities of a fast and a slow neuromuscular system of the rat.

Storella RJ Jr, Riker WF, Baker T.

Eur J Pharmacol. 1985 Nov 26;118(1-2):181-4.

PMID:
4085548
9.

Prolongation of procaine's and procainamide's actions by binding to acryloyl polymers.

Erker EF, Baker T, Okamoto M, Udenfriend S, Riker WF Jr.

Eur J Pharmacol. 1985 Aug 27;114(3):253-9.

PMID:
4065200
10.
11.

A morphological study of the effect of glucocorticoid treatment on delayed organophosphorus neuropathy.

Drakontides AB, Baker T, Riker WF Jr.

Neurotoxicology. 1982 Dec;3(4):165-77.

PMID:
6304583
12.

Prevention of the organophosphorus neuropathy by glucocorticoids.

Baker T, Drakontides AB, Riker WF Jr.

Exp Neurol. 1982 Nov;78(2):397-408. No abstract available.

PMID:
6291977
13.

Interactions of quaternary ammonium drugs with acetylcholinesterase and acetylcholine receptor of Torpedo electric organ.

Bakry NM, Eldefrawi AT, Eldefrawi ME, Riker WF Jr.

Mol Pharmacol. 1982 Jul;22(1):63-71. No abstract available.

PMID:
7121452
14.

Regional high-affinity [3H]choline accumulation in cat forebrain: selective increase in the caudate-putamen after corticosteroid pretreatment.

Riker DK, Sastre A, Baker T, Roth RH, Riker WF Jr.

Mol Pharmacol. 1979 Nov;16(3):886-99. No abstract available.

PMID:
530261
15.

A benzodiazepine-anticholinergic drug synergism in the prevention of stress-induced gastric mucosal erosion in mice.

Baker T, Riker WF, Zeldes G.

J Clin Pharmacol. 1979 Aug-Sep;19(8-9 Pt 1):409-14.

PMID:
314947
16.

Myokymia and impaired muscular relaxation with continuous motor unit activity.

Lublin FD, Tsairis P, Streletz LJ, Chambers RA, Riker WF, Van Poznak A, Duckett SW.

J Neurol Neurosurg Psychiatry. 1979 Jun;42(6):557-62.

17.

The neuropathology of DFP at cat soleus neuromuscular junction.

Glazer EJ, Baker T, Riker WF Jr.

J Neurocytol. 1978 Dec;7(6):741-58.

PMID:
731281
18.

Glucocorticoid effects on spinal cord function.

Hall ED, Baker T, Riker WF Jr.

J Pharmacol Exp Ther. 1978 Aug;206(2):361-70. No abstract available.

PMID:
210274
19.

Functional, pharmacologic, and ultrastructural correlates in degenerating rat motor nerve terminals.

Drakontides AB, Riker WF Jr.

Exp Neurol. 1978 Mar;59(1):112-23. No abstract available.

PMID:
627259
20.
21.

Effects of a single methylprednisolone dose on a facilitatory response of mammalian motor nerve.

Baker T, Riker WF, Hall ED.

Arch Neurol. 1977 Jun;34(6):349-55.

PMID:
193476
22.

Glucocorticoid preservation of motor nerve function during early degeneration.

Hall ED, Baker T, Riker WF Jr.

Ann Neurol. 1977 Mar;1(3):263-9. No abstract available.

PMID:
196542
23.

Glucocorticoids and mammalian motor nerve excitability.

Riker WF Jr, Baker T, Okamoto M.

Arch Neurol. 1975 Oct;32(10):688-94.

PMID:
1180732
24.

Motor nerve terminal response to edrophonium in delayed DFP neuropathy.

Lowndes HE, Baker T, Riker WF Jr.

Eur J Pharmacol. 1975 Jan;30(1):69-72.

PMID:
1122938
25.

Motor nerve dysfunction in delayed DFP neuropathy.

Lowndes HE, Baker T, Riker WF Jr.

Eur J Pharmacol. 1974 Nov;29(1):66-73. No abstract available.

PMID:
4435046
26.

Educational and Professional Affairs Committee of ASPET.

Riker WF Jr.

Fed Proc. 1974 Sep;33(9):1992-4. No abstract available.

PMID:
4418035
27.

Further observations on subacute denervation and mammalian motor nerve terminal function.

Bunn PA Jr, Okamoto M, Riker WF Jr.

Neurology. 1973 Jan;23(1):12-20. No abstract available.

PMID:
4347059
28.
29.

Destruction of mammalian motor nerve terminals by black widow spider venom.

Okamoto M, Longenecker HE Jr, Riker WF Jr, Song SK.

Science. 1971 May 14;172(3984):733-6.

PMID:
4324667
30.

Subacute denervation: a means of disclosing mammalian motor nerve terminals as critical sites of acetylcholine and facilitatory drug actions.

Okamoto M, Riker WF Jr.

J Pharmacol Exp Ther. 1969 Apr;166(2):217-24. No abstract available.

PMID:
4304912
31.

Pharmacology of motor nerve terminals.

Riker WF Jr, Okamoto M.

Annu Rev Pharmacol. 1969;9:173-208. Review. No abstract available.

PMID:
4307019
32.
33.

Actions of acetylcholine on mammalian motor nerve terminal.

Riker WF Jr.

J Pharmacol Exp Ther. 1966 Jun;152(3):397-416. No abstract available.

PMID:
5922310
34.

The action of facilitatory drugs and acetylcholine on neuromuscular transmission.

Riker WF Jr, Standaert FG.

Ann N Y Acad Sci. 1966 Jan 26;135(1):163-76. No abstract available.

PMID:
5221338
35.

ACETYLCHOLINE RELEASE AT THE NEUROMUSCULAR JUNCTION.

HAYES AH Jr, RIKER WF Jr.

J Pharmacol Exp Ther. 1963 Nov;142:200-5. No abstract available.

PMID:
14085497
36.

The quantitative evaluation of autonomic drugs on the isolated eye.

BEAVER WT, RIKER WF.

J Pharmacol Exp Ther. 1962 Oct;138:48-56. No abstract available.

PMID:
13970022
37.

Contributions to medicine by research in pharmacology. Some aspects of dosage.

RIKER WF Jr.

JAMA. 1962 Feb 3;179:355-60. No abstract available.

PMID:
14492275
38.

The relationship between cholinesterase inhibition and drug-induced faciliation of mammalian neuromuscular transmission.

KUPERMAN AS, GILL EW, RIKER WF.

J Pharmacol Exp Ther. 1961 Apr;132:65-73. No abstract available.

PMID:
13755220
39.

Pharmacologic considerations in a reevaluation of the neuromuscular synapse.

RIKER WF Jr.

Arch Neurol. 1960 Nov;3:488-99. No abstract available.

PMID:
13741664
40.

Pharmacologic evidence for the existence of a presynaptic event in neuromuscular transmission.

RIKER WF Jr, WERNER G, ROBERTS J, KUPERMAN A.

J Pharmacol Exp Ther. 1959 Feb;125(2):150-8. No abstract available.

PMID:
13631615
41.

The motor nerve terminal as the primary focus for drug-in-duced facilitation of neuromuscular transmission.

RIKER WF Jr, ROBERTS J, STANDAERT FG, FUJIMORI H.

J Pharmacol Exp Ther. 1957 Nov;121(3):286-312. No abstract available.

PMID:
13481851
42.

The initiation and pharmacologic reactivity of a ventricular pacemaker in the intact animal.

RIKER WF Jr, ROBERTS J, STANDAERT F, KIM YUNG IN.

J Pharmacol Exp Ther. 1956 Aug;117(4):374-84. No abstract available.

PMID:
13358049
43.

The use of certain neuromuscular blocking drugs in an analysis of ventricular irregularities induced in the cat.

ROBERTS J, ROY BB, REILLY J, GARB S, RIKER WF Jr, HASHIMOTO K.

J Pharmacol Exp Ther. 1955 Jul;114(3):279-88. No abstract available.

PMID:
13243239
44.

The epinephrine and hydrocarbon-epinephrine disturbance in the cat.

RIKER WF, DEPIERRE F, ROBERTS J, ROY BB, REILLY J.

J Pharmacol Exp Ther. 1955 May;114(1):1-9. No abstract available.

PMID:
14392564
45.

The actions of methylfluoroacetate on the papillary muscle of the cat with comparative experiments on the actions of methyl chloroacetate.

REILLY J, RIKER WF Jr, WHITEHOUSE WC, KURIAKI K.

J Pharmacol Exp Ther. 1953 Aug;108(4):393-409. No abstract available.

PMID:
13070160
46.

Some aspects of the pharmacology of neuromuscular function.

RIKER WF Jr.

Am J Med. 1953 Aug;15(2):231-49. No abstract available.

PMID:
13065323
47.
48.

Pharmacology of anti-curare agents.

WESCOE WC, RIKER WF.

Int Rec Med Gen Pract Clin. 1951 Dec;164(12):718. No abstract available.

PMID:
14897468
49.

Pharmacology of flaxedil.

RIKER WF, WESCOE WC.

Int Rec Med Gen Pract Clin. 1951 Dec;164(12):716. No abstract available.

PMID:
14897467
50.

The effects of a synthetic curare-like compound, the tri-iodo salt of tris (triethylaminoethoxy) 1,2,3 benzene (Flaxedil), on the anesthetized surgical patient.

MARBURY BE, ARTUSIO JF Jr, WESCOE WC, RIKER WF Jr.

J Pharmacol Exp Ther. 1951 Nov;103(3):280-7. No abstract available.

PMID:
14898443

Supplemental Content

Loading ...
Support Center